Moody's: Fresenius still on review

Moody's Investors Service said that the Ba1 corporate family rating of Fresenius SE remains on review for downgrade following the company's announcement on June 29 that its bid to acquire Rhon Klinikum AG has failed to achieve the required 90% acceptance.

Moody's said it will maintain Fresenius SE's rating on review for downgrade given that the transaction could still go ahead, albeit possibly on modified terms, with the company having communicated that it will be exploring its options over coming days or weeks.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.